AGN 2.41% 81.0¢ argenica therapeutics limited

Date of first participant...

  1. 41 Posts.
    lightbulb Created with Sketch. 53
    Date of first participant enrolment
    Anticipated

    https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=385922&isReview=true&fbclid=IwAR1xc4Fq-4GGYxRgQ-pAiQbmlFFGsPmlHhbopn6N4XB61f4S18WNe8swv1k
    View organization page for Argenica Therapeutics

    1,312 followers

    3d

    Welcome back to 2024!This year is gearing up to be even bigger than 2023 for Argenica Therapeutics, with Phase 2 clinical trial in acute ischaemic stroke (AIS) patients right around the corner.If you missed it, last month we provided a company update that addressed the current status of the clinical trial.⬇ You can find the announcement here ⬇ AGN investor announcement: https://bit.ly/3NVPdWu#ASX#AGN#investor#clinicaltrial#clinicaltrialupdate#stroke#strokeawareness

    • No alternative text description for this image

    https://www.linkedin.com/posts/argenica-therapeutics_asx-agn-investor-activity-7149920317258293248-jYR_
 
watchlist Created with Sketch. Add AGN (ASX) to my watchlist
(20min delay)
Last
81.0¢
Change
-0.020(2.41%)
Mkt cap ! $102.9M
Open High Low Value Volume
85.0¢ 85.5¢ 81.0¢ $80.99K 98.04K

Buyers (Bids)

No. Vol. Price($)
2 20011 81.0¢
 

Sellers (Offers)

Price($) Vol. No.
85.0¢ 10000 1
View Market Depth
Last trade - 16.10pm 19/08/2024 (20 minute delay) ?
AGN (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.